Large-scale testing (Phase 3)UnknownNCT01172392
What this trial is testing
Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis B
Who this might be right for
Chronic Hepatitis BAgHbs Negativation
ANRS, Emerging Infectious Diseases 185